Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Burosumab granted FDA orphan drug status for tumor-induced osteomalacia syndrome

June 22, 2017

AbbVie's lutikizumab fails primary endpoint in a phase IIa trial for hand OA

June 21, 2017

Biocad's BCD-055 demonstrates equivalence to infliximab in clinical trials

June 21, 2017

Seikagaku initiates phase II study in U.S. with SI-613 for knee osteoarthritis

June 19, 2017

Human pluripotent stem cells used for cartilage repair in animal models

June 19, 2017

Mitsubishi Tanabe Pharma discovers MC1 receptor agonists

June 16, 2017

ACEA completes phase I trial of AC-0058

June 15, 2017

FDA grants rare pediatric disease designation to Fibrocell Science's FCX-013

June 13, 2017

Medivir gives update on phase IIa extension study of MIV-711

June 12, 2017

Upadacitinib meets all primary and secondary endpoints in phase III SELECT-NEXT study

June 9, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...